已收盘 06-26 16:00:00 美东时间
+3.180
+3.29%
今日重点评级关注:Chardan Capital:维持Ocular Therapeutix"买入"评级,目标价从21美元升至23美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从30美元升至40美元
06-26 17:42
瑞银分析师凯文·麦克维维持Paychex的投资评级为“中性”,同时将其目标价从100美元下调至98美元。 译文内容由第三方软件翻译。 声明:市场有风险,投资需谨...
06-26 04:02
While Paychex Inc’s (NASDAQ:PAYX) fiscal 2026 results were "noisy," the setup for fiscal 2027 appears "cleaner," according to Guggenheim Securities. The Paychex Analyst: Analyst Jacob Smith reiterated a Neutral rating on the stock. The Paychex Thesis: The company reported its fiscal fourth-quarter ...
06-26 03:44
JP Morgan analyst Tien-Tsin Huang maintains Paychex (NASDAQ:PAYX) with a Underweight and raises the price target from $100 to $105.
06-25 22:45
Earnings Call Insights: Paychex, Inc. (PAYX) Q4 fiscal 2026 Management View CEO John Gibson said Paychex exited fiscal 2026 with “strong momentum,” citing “double-digit revenue and earnings growth in ...
06-25 02:53
Paychex Inc. (NASDAQ:PAYX) reported fourth-quarter results that topped Wall Street expectations on Wednesday, but shares declined after the payroll and human capital management provider issued fiscal 2027 revenue guidance that came in slightly below analyst estimates. Guidance Overshadows Earnings B...
06-25 00:46
沛齐公司(Paychex, Inc.)公布2026财年第四季度财报,调整后收益超市场共识预期,营收同步小幅超预期。同期Verisk分析公司、埃森哲公司也发布最新...
06-25 00:27
Paychex forecasts slower fiscal 2027 revenue growth, shares dip June 24 (Reuters) - HR and payroll services provider Paychex PAYX.O forecast slower revenue growth for fiscal 2027 on Wednesday, overshadowing a quarterly revenue beat and sending its shares down 4% in early trading. Here are some detai
06-24 22:10
Paychex (PAYX) stock fell 4.8% in Wednesday premarket trading after Q4 earnings and revenue, roughly in line with Wall Street consensus estimates, even as SG&A expenses exceeded analysts' expectations...
06-24 21:27